Analysis in a group dosing study [Bioanalytics]

posted by jag009  – NJ, 2015-07-22 18:23 (3597 d 01:41 ago) – Posting: # 15127
Views: 3,810

Hi,

❝ We are planning to conduct a FDA submission study in 3 groups (due to logistic limitations).


Is this a parallel study or a crossover study with groups?

You have a timeline issue? If not, I would prefer to finish all dosing and PK samplings before starting bioanalytical.

John

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,675 registered users;
61 visitors (0 registered, 61 guests [including 10 identified bots]).
Forum time: 20:05 CEST (Europe/Vienna)

Do not worry about your difficulties in mathematics.
I can assure you mine are still greater.    Albert Einstein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5